BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.1150
0.00 (0.00%)
Feb 4, 2026, 3:46 PM AEST
BCAL Diagnostics Revenue
In the fiscal year ending June 30, 2025, BCAL Diagnostics had annual revenue of 2.65M AUD, down -13.01%. BCAL Diagnostics had revenue of 1.27M in the half year ending June 30, 2025, a decrease of -29.04%.
Revenue
2.65M
Revenue Growth
-13.01%
P/S Ratio
15.97
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.65M | -396.37K | -13.01% |
| Jun 30, 2024 | 3.05M | 256.17K | 9.18% |
| Jun 30, 2023 | 2.79M | 2.07M | 288.29% |
| Jun 30, 2022 | 718.67K | 443.42K | 161.09% |
| Jun 30, 2021 | 275.25K | -166.84K | -37.74% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.34B |
| Australian Clinical Labs | 741.27M |
| Integral Diagnostics | 627.22M |
| Monash IVF Group | 271.92M |
| Genetic Signatures | 19.75M |
| Microba Life Sciences | 15.67M |
| Cryosite | 14.12M |
| Genetic Technologies | 9.17M |